Percutaneous valve‐in‐valve procedure and simultaneous paravalvular leak closure

Concern for early degeneration limits the use of bioprosthetic heart valves. A 77‐year‐old man who underwent surgical aortic valve replacement at age 70 for severe aortic stenosis (AoS) presented with premature bioprosthesis degeneration and AoS recurrence. Transthoracic echocardiography demonstrate...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiac surgery Vol. 34; no. 11; pp. 1408 - 1410
Main Authors Balanescu, Dinu V., Cebotaru, Theodor, Iancu, Adrian C., Dregoesc, Ioana M., Balanescu, Serban M.
Format Journal Article
LanguageEnglish
Published United States 01.11.2019
Subjects
cardiovascular pathology
valve repair/replacement
valve repair/replacement
cardiovascular pathology
Online AccessGet full text

Cover

More Information
Summary:Concern for early degeneration limits the use of bioprosthetic heart valves. A 77‐year‐old man who underwent surgical aortic valve replacement at age 70 for severe aortic stenosis (AoS) presented with premature bioprosthesis degeneration and AoS recurrence. Transthoracic echocardiography demonstrated severe AoS and aortic regurgitation, a 30% ejection fraction, and pulmonary hypertension. Transesophageal echocardiography revealed that the aortic regurgitation was due to a 5‐mm paravalvular leak (PVL). A high EuroScoreII excluded surgical treatment. Simultaneous transcatheter aortic valve replacement and PVL closure with an Occlutech PLD Square 5 Twist PVL closure device were performed with good results and improved clinical status.
ISSN:0886-0440
1540-8191
DOI:10.1111/jocs.14240